-Synuclein and dopamine at the crossroads of Parkinsons disease
Henry Legere is a Columbia-trained physician, Harvard immunologist, and serial healthcare entrepreneur shaping the future of digital medicine and longevity
But the drugs journey into mainstream culture wasnt driven by endocrinology journals
This situation feels different from other drug classes because it is: diabetes and obesity are massive markets, and beyond the FDA approved indicated populations, theres a swath of people interested in getting their hands on GLP-1 agonists off-label to help them lose a few extra pounds
According to a March 2024 analysis by the Congressional Budget Office, the drug is expected to be included in future CMS price negotiations
It's not the kind of acid you're thinking!) such as glycolic acid, lactic acid, salicylic acid can do wonders for a whole host of issues from pigmentation to acne